Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 20 Aug 2025, 12:30 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The video analyzes UNH, stating its current price at $271.49 but calculating its intrinsic value at $430, implying it is undervalued. It mentions Warren Buffet's Berkshire Hathaway taking a stake, increasing shares by 10%. The presenter considers a higher than average risk with UnitedHealth group estimating a cost of 6.5 billion dollars in 2025 and adjusting the risk measure for the company's shares and the weighted average cost of capital is 10.4%. Free cash flow is expected at $375 billion.The analysis also estimates Novo Nordisk's intrinsic value per share at $127, while its current market price is $51.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.